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The multi-subunit protein complex, cohesin, is responsible for sister chromatid cohesion
during cell division. The interaction of cohesin with DNA is controlled by a number of
additional regulatory proteins. Mutations in cohesin, or its regulators, cause a spectrum
of human developmental syndromes known as the “cohesinopathies.” Cohesinopathy
disorders include Cornelia de Lange Syndrome and Roberts Syndrome. The discovery
of novel roles for chromatid cohesion proteins in regulating gene expression led to the
idea that cohesinopathies are caused by dysregulation of multiple genes downstream
of mutations in cohesion proteins. Consistent with this idea, Drosophila, mouse, and
zebrafish cohesinopathy models all show altered expression of developmental genes. How-
ever, there appears to be incomplete overlap among dysregulated genes downstream of
mutations in different components of the cohesion apparatus. This is surprising because
mutations in all cohesion proteins would be predicted to affect cohesin’s roles in cell divi-
sion and gene expression in similar ways. Here we review the differences and similarities
between genetic pathways downstream of components of the cohesion apparatus, and
discuss how such differences might arise, and contribute to the spectrum of cohesinopa-
thy disorders. We propose that mutations in different elements of the cohesion apparatus
have distinct developmental outcomes that can be explained by sometimes subtly different
molecular effects.
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INTRODUCTION
The cohesin complex and proteins that regulate its interaction
with chromatin have multiple roles in cell division, DNA damage
repair, gene transcription, and chromosome architecture. Proteins
that make up the cohesin complex have been characterized in sev-
eral model systems (see Table 1). The mechanics of cell division
has been well researched for decades, and the identity of the chro-
mosome cohesion proteins that hold together sister chromatids
after S phase and prior to mitosis has been known for 15 years
(Guacci et al., 1997; Michaelis et al., 1997). Consequently, sister
chromatid cohesion remains the best-characterized role for the
cohesin complex and its regulators.
The first evidence that a transcriptional function existed
for chromosome cohesion proteins emerged in 1999, when the
Nipped-B gene was identified in a genetic screen for modifiers
of long-range enhancer-promoter communication regulating cut
gene expression in the Drosophila wing margin (Rollins et al.,
1999). Further evidence that gene transcription isone of cohesin’s
crucial functions unfolded over the following years, and included
a role for Scc1 in mating-type silencing in yeast (Lau et al., 2002),
a transcriptional co-activation function for SA in mammalian cell
lines (Lara-Pezzi et al., 2004), and complex long-range regula-
tion of cut gene expression resulting from cohesin and Nipped-B
Drosophila mutants (Rollins et al., 2004). Interest in the tran-
scription function of cohesion proteins heightened when het-
erozygous mutations NIPBL, the human homolog of Nipped-B,
were found to cause the human developmental disease, Cor-
nelia de Lange Syndrome (CdLS; OMIM 122470; Krantz et al.,
2004; Tonkin et al., 2004). Additional mutations causing CdLS
were found in the cohesin subunits SMC1 (Musio et al., 2006;
Deardorff et al., 2007) and SMC3 (Deardorff et al., 2007). Fur-
thermore, homozygous mutations in ESCO2, which encodes a
cohesion acetyltransferase (CoAT; Nasmyth, 2011; Higashi et al.,
2012), were found to underlie a second human disorder, Robert’s
Syndrome (RBS; OMIM 268300; Vega et al., 2005). More recently,
mutations in RAD21 have been found to cause a related develop-
mental disorder that partially overlaps with CdLS (Deardorff et al.,
2012b).
After the causative genes for CdLS and RBS were found, a flood
of new results in vertebrates, from fish (Horsfield et al., 2007;
Muto et al., 2011), mouse (Zhang et al., 2007, 2009; Kawauchi
et al., 2009), and human cell lines (Liu et al., 2009), supported
the notion that these syndromes could be caused by dysregulated
expression of multiple developmental genes. This suggested that
cohesin-related developmental disorders have related patholo-
gies, and led to use of the term “cohesinopathies” to describe
these disorders (Liu and Krantz, 2008; McNairn and Gerton,
2008).
Although the idea that cohesinopathies have a common causal
basis in dysregulated gene expression is a popular one, it is clear
that the output of gene regulation is different for each disorder.
Human syndromes caused by NIPBL, SMC1, SMC3, RAD21, and
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Table 1 | Nomenclature and function of cohesin subunits and cohesin regulators.
Chromosome
cohesion
regulator
S. cerevisiae S. pombe D. melanogaster X. laevis D. rerio H. sapiens Function
SMC subunits Smc1 Psm1 SMC1 smc1a1 Smc1al,
Smc1a2
SMC1A Core cohesin subunit
smc1b1 Smc1b SMC1B Cohesin subunit (meiosis)
Smc3 Psm3 Cap/SMC3 smc3/cspg61 Smc3 SMC3/CSPG6/
Bamacan
Core cohesin subunit
α-Kleisin subunit Mcd1/Scc1 Rad21 Vtd/Rad21 rad21/mcd1/nxp1
/scc11
Rad21a,
Rad21b2
RAD21 Core cohesin subunit
Rec8 Rec8 C(2)M rec8 Rec8/zgc:
1368881,3
REC8 Cohesin subunit (meiosis)
– – – Rad21l1 RAD21L1/RAD21L
Stromalin/SA
subunit
Psc3 SA (stromalin) stag1/sa1 Stag11,3 STAG1/SA1/SCC3A Cohesin subunit
SA2 (stromalin-2) stag2/sa21 Stag21,3 STAG2/SA2/SCC3B
– Rec11 – stag3/sa31 Stag3l31 STAG3/SA3 Cohesin subunit (meiosis)
Interactors of
α-kleisin and SA
Pds5 Pds5 Pds5 pds5a Pds5a/zgc:
66331
PDS5A Balancing cohesion
establishment with cohesin
dissociationpds5b/as3/aprin1 Pds5b1 PDS5B/APRIN/AS3
? ? Dmt (Dalmatian) cdca5/sororin1 Cdca5 CDCA5/SORORIN
Rad61/Wpl1 Wapl Wapl wapal Wapl/KIAA
02611,3
WAPAL/WAPL
Kollerin Scc2 Mis4 Nipped-B nipbl/scc2/delangin Nipbla/Scc2a,
Nipblb/Scc2b
NIPBL/SCC2/
DELANGIN
Cohesin loading
Scc4 Ssl3 mau2/scc41 Mau2/zgc:
1123381
MAU2/SCC4
Cohesin acetyl
transferase
(CoAT)
Eco1/Ctf7 Eso1 Eco/Deco esco1 Esco11 ESCO1 Establishment of cohesion
San esco2/rbs/efo21 Esco2 ESCO2
Cohesin
deacetylase
(CoDAC)
Hos1 ? ? hdac8 Hdac8 HDAC8 Recycling of cohesin
1Predicted/in silico annotated only.
2No functional data available.
3Duplicated (EnsemblZv9, release 68).
?, protein not yet identified.
ESCO2 mutations share common features but appear to be clin-
ically distinct. Here we revisit the theory that cohesinopathies
result from dysregulated gene expression, and raise the ques-
tion of whether subunits contributing to cohesin or its regulation
can interact separately with distinct pathways leading to diverse
phenotypic consequences.
OVERVIEW OF COHESIN STRUCTURE AND FUNCTION
The mitotic cohesin complex comprises two structural mainte-
nance of chromosomes (SMC) subunits Smc1 and Smc3, which
associate to form a tripartite ring incorporating an α-kleisin sub-
unit, Mcd1/Scc1/Rad21. Smc1 and Smc3 are large rod-shaped
proteins that dimerize at one end to form a “hinge” domain, and
also interact at the other end via ATP-binding “heads,” which in
turn interact with the α-kleisin subunit (Figure 1). The α-kleisin
interacts with additional subunits Scc3/Stromalin (SA), Pds5, and
Wapl (Nasmyth, 2011; see Table 1). The formation of cohesin
subunits into a large ring structure led to the theory that cohesin
topologically entraps sister chromatids inside a single ring (Haer-
ing et al., 2008). Alternative models have been proposed for how
cohesin physically holds two molecules of DNA together (Huang
et al., 2005; Zhang et al., 2008b; Skibbens, 2010), although most are
not compatible with the single ring theory (reviewed in Nasmyth,
2011).
The many functions of cohesin have been well described in
recent reviews (Hirano, 2006; Nasmyth and Haering, 2009; Car-
retero et al., 2010; Nasmyth, 2011; Rhodes et al., 2011; Mehta
et al., 2012). Cohesin turnover, recycling, loading onto chromo-
somes and residency there is controlled by several other pro-
teins (Figure 2; Table 1). It was recently proposed that cohesin
is loaded and unloaded from chromosomes by a “dual gate”
mechanism (Nasmyth, 2011). The cohesin loading complex con-
taining Scc2 (Nipped-B in Drosophila and NIPBL in human)
and Scc4/MAU2, recently dubbed “kollerin” (Nasmyth, 2011), is
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FIGURE 1 | Overview of the cohesin complex and its associated
proteins. The cohesin complex consists of four core subunits: SMC1,
SMC3, RAD21, and SA. Together these subunits form a large ring capable
of topologically encircling DNA strands. Other proteins regulate cohesin’s
binding to DNA and its residency there. The NIPBL/MAU2 dimer loads
cohesin onto DNA, whereas WAPL/PDS5 release cohesin from
chromosomes by opening the SMC3-RAD21 interface.
responsible for loading cohesin onto chromosomes in G1 phase
in yeast, and telophase in most other organisms. Kollerin directly
loads cohesin onto the pre-replication complex (pre-RC) on chro-
matin in vitro in Xenopus extracts (Bermudez et al., 2012), indi-
cating that it is likely to be necessary and sufficient for cohesin
loading. Kollerin likely facilitates cohesin loading by enabling the
transient opening of the Smc1-Smc3 hinge domains (Figure 1;
Nasmyth, 2011). An opposing unloading activity is mediated
by “releasin,” a cohesion disestablishment complex containing
Pds5 and Wapl that interacts with SA to unlock the cohesin
ring (Gandhi et al., 2006; Kueng et al., 2006; Shintomi and
Hirano, 2009). Releasin allows exit of DNA via the Smc1-Smc3
head domains by opening the Smc3-kleisin interface. In theory,
cohesin snaps onto DNA via opening of the hinge domains, and
exits DNA via opening the ring at the opposite end (Nasmyth,
2011).
Once loaded onto chromosomes, cohesin binds DNA with vari-
able modes of stability (Gerlich et al., 2006; Gause et al., 2010) and
is mobile, having the ability to translocate along chromosome arms
(Lengronne et al., 2004; Hu et al., 2011), or readily detach via inter-
action with releasin. However during S phase, cohesin becomes
stably bound for long enough to fulfill its function in sister chro-
matid cohesion. Stabilization of cohesin binding happens during
the process of DNA replication (Skibbens et al., 1999; Kenna and
Skibbens, 2003; Moldovan et al., 2006), and is mediated via acetyla-
tion of Smc3 by cohesin acetyl transferase (CoAT; Nasmyth, 2011).
The known CoATs for Smc3 are Ctf7/Eco1 (yeast), or Esco1/2 (ver-
tebrates; Skibbens et al., 1999; Ivanov et al., 2002; Hou and Zou,
2005).
CoAT-mediated acetylation of Smc3 generates the cohesive
form of cohesin that holds together the sister chromatids from G2
until M phase (Ben-Shahar et al., 2008; Unal et al., 2008; Zhang
et al., 2008a). In humans, both ESCO1 and ESCO2 CoATs are nec-
essary for proper sister chromatid cohesion (Hou and Zou, 2005).
However, it appears that ESCO2 CoAT is primarily required for
cohesion in heterochromatic regions, and RBS patients who lack
ESCO2 exhibit heterochromatin repulsion and precocious sister
chromatid separation, particularly at centromeric regions (Vega
et al., 2005). In human and Drosophila (but not yeast), the Sororin
protein is additionally required to establish and maintain cohe-
sion (Rankin et al., 2005; Schmitz et al., 2007; Nishiyama et al.,
2010).
Once cohesion has been established in G2, cohesion-promoting
and cohesin-releasing activities compete during chromosome con-
densation in prophase. The releasing activity that removes cohesin
from chromosomes prevails along chromosome arms in a process
known as the “prophase pathway,” which involves phosphoryla-
tion of SA1/2 by Polo-like kinase (Plk) and Aurora B (Losada
et al., 2002; Hauf et al., 2005) and complexing of SA and RAD21
by releasin (Gandhi et al., 2006; Kueng et al., 2006; Shintomi and
Hirano, 2009). In the competing “establishment” activity, Sororin
and CoAT function to antagonize releasin activity (Rowland et al.,
2009; Sutani et al., 2009; Lafont et al., 2010; Nishiyama et al.,
2010; Nasmyth, 2011) by a mechanism that also requires Pds5
(Vaur et al., 2012), and the phosphatase Ssu72 promotes cohe-
sion by countering the phosphorylation of SA1/2 (Hauf et al.,
2005; Kim et al., 2010b). By metaphase, most cohesin has been
removed from chromosome arms, and the remaining, primar-
ily centromeric cohesin, is protected from removal by Shugoshin
(Wang and Dai, 2005).
At Anaphase, the remaining cohesin rings are opened, allow-
ing chromosomes to separate (Craig and Choo, 2005). APC-
mediated degradation of Securin (Salah and Nasmyth, 2000)
releases the protease Separase, which cleaves the Rad21 subunit
of cohesin (Waizenegger et al., 2000, 2002; Hornig et al., 2002).
After telophase, Smc complexes can be recycled and reloaded
onto chromatin. An important requirement for cohesin recy-
cling is deacetylation of Smc3 by the class I histone deacety-
lase Hos1 (yeast) or HDAC8 (human; Beckouet et al., 2010;
Borges et al., 2010; Xiong et al., 2010; Deardorff et al., 2012a).
Thus, Smc3 deacetylation by Hos1 opposes Esco2’s acetylation
activity.
Cohesin has a further important role in DNA double strand
break repair (reviewed in Dorsett and Strom, 2012; Wu and Yu,
2012). To effect double strand break repair, the cohesive form of
cohesin must be established at the location of the break (Ball and
Yokomori, 2008). Stabilization of cohesin at double strand breaks
in budding yeast depends on acetylation of the Rad21/Mcd1p
subunit by Eco1p, plus antagonism of the releasin complex con-
taining Wpl (Heidinger-Pauli et al., 2009). Cohesin is recruited
de novo at double strand breaks in G2 phase (Strom et al., 2007)
in a Scc2/kollerin-dependent manner (Strom et al., 2004), and in
vertebrates, this association also involves another SMC complex:
the Smc5/6 complex (Strom and Sjogren, 2007; De Piccoli et al.,
2009).
Other molecular events contribute to cohesin function in DSB
repair. In budding yeast, it was shown that the phosphorylation
of Mcd1p (Rad21) through ATR and Chk1 pathway is important
for cohesion and DSB repair (Heidinger-Pauli et al., 2008). In
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FIGURE 2 | Comparison of the top 200 affected probe sets in zebrafish embryos depleted of different cohesin subunits. Venn diagrams showing the
overlap of the top 200 probe sets affected in zebrafish esco2 and nipbl morphants, and smc1ahi1113a and rad21nz171 mutants at 24 and 48 hpf (q value< 0.05).
human cells, cohesive cohesin at DSBs also depends on the pro-
establishment activity of Sororin (Schmitz et al., 2007). Cohesin,
but not chromosome cohesion, is required for activation of G1,
intra-S, and G2–M DNA damage checkpoints (Jessberger, 2009;
Watrin and Peters, 2009). In cancer cells, cohesin binding through
the genome is reinforced following ionizing radiation (IR), in a
process that requires ATM and SMC3 phosphorylation, and SMC3
acetylation by ESCO1. Both ESCO1 and SMC3 acetylation are
required for intra-S phase checkpoint and cellular survival after
IR (Kim et al., 2010a).
COHESIN AND MECHANISMS OF GENE TRANSCRIPTION
Despite good evidence that cohesin regulates gene expression
directly and independently of cell division (Pauli et al., 2010;
Dorsett, 2011), the mechanism(s) of transcriptional regulation
by cohesin are not well understood. Cohesin binds to many
sites throughout the genome, sometimes in combination with
the CCCTC-binding factor (CTCF) insulator protein, which is
known to mediate chromatin loop formation (Gondor and Ohls-
son, 2008). Previous studies demonstrated that cohesin colocalizes
with CTCF along chromosome arms, and is likely to cooperate
with this protein in the regulation of gene expression or chro-
matin structure (Parelho et al., 2008; Rubio et al., 2008; Wendt
et al., 2008). As well as CTCF, cohesin colocates genome-wide
with other transcriptional regulators, such as estrogen receptor-
α (Schmidt et al., 2010), and Mediator (Kagey et al., 2010) in a
cell type-specific manner. Likely in combination with other fac-
tors, cohesin selectively binds genes with paused RNA polymerase.
Although it is not involved in RNA polymerase pausing itself,
cohesin can regulate transcription by determining the amount of
elongating RNA polymerase on genes (Fay et al., 2011).
Regulation of many genes by cohesin appears to involve the
three-dimensional (3D) organization of chromatin (Merken-
schlager, 2010; Dorsett, 2011). A direct role for cohesin in chro-
matin looping has been demonstrated for several loci (Hadjur
et al., 2009; Mishiro et al., 2009; Nativio et al., 2009; Hou et al.,
2010; Chien et al., 2011; Kim et al., 2011) by studies show-
ing that long-range interactions between regulatory sequences
are reduced by cohesin knockdown. It is likely that cohesin
regulates spatiotemporal gene expression in combination with
diverse tissue-specific transcription factors, and by distinct modes
of transcription regulation (Dorsett, 2011).
THE HUMAN COHESINOPATHIES
An overlapping spectrum of human syndromes can be attributed
to mutations in cohesin subunits, or regulators of cohesin loading
and unloading from chromosomes. The best known cohesinopa-
thy is CdLS (OMIM 122470) also termed Brachmann de Lange
syndrome (BdLS), a broad spectrum disorder with multiple devel-
opmental and cognitive abnormalities (de Lange, 1933; Opitz,
1985; Ireland et al., 1993; Jackson et al., 1993). CdLS patients are
small in size and have a characteristic facial appearance, includ-
ing arched eyebrows, hirsutism, synophrys, ptosis, long eyelashes,
an upturned nose, a long philtrum, thin upper lip, and microg-
nathia. Developmental anomalies range from mild to severe, with
more severe cases having upper limb truncations or limb differ-
ences. CdLS patients also frequently present with hearing loss,
gastrointestinal defects, pyloric stenosis, genital abnormality, con-
genital diaphragmatic hernias, cardiac septal defects, and autistic
behaviors (Jackson et al., 1993). All patients within the CdLS spec-
trum have neurodevelopmental delay and highly variable mental
retardation (Deardorff et al., 2007).
More than half of CdLS cases (∼65%) are dominantly inher-
ited, and caused by mutations in the NIPBL gene (OMIM 608667;
Krantz et al., 2004; Tonkin et al., 2004), which encodes a cru-
cial component of kollerin. Heterozygous truncating or non-sense
NIPBL mutations are haploinsufficient, and strikingly, NIPBL pro-
tein levels need only be reduced by 15–30% to give rise to a CdLS
phenotype (Krantz et al., 2004; Tonkin et al., 2004). This implies
that the remaining intact NIPBL allele is upregulated in an attempt
to compensate, and also that certain cell types and/or develop-
mental processes are exquisitely sensitive to the levels of NIPBL.
Missense mutations in NIPBL were also identified that may inter-
fere with the interaction of NIPBL with its partner, MAU2, or other
proteins (Braunholz et al., 2012).
Mutations in SMC1A (OMIM 300040) and SMC3 (OMIM
606062) also give rise to syndromes that fall within the CdLS spec-
trum, and account for about 5% of CdLS cases (Musio et al., 2006;
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Deardorff et al., 2007; Mannini et al., 2010). SMC mutations are
heterozygous missense mutations and are thought to interfere with
the structure of the SMC subunits such that functional interactions
of the cohesin complex are disturbed, causing the disease pathol-
ogy (Deardorff et al., 2007). In some cases missense mutations
were shown to interfere with cohesin binding to DNA (Revenkova
et al., 2009). Human developmental phenotypes resulting from
SMC mutations are inclined to be milder than for NIPBL muta-
tions; these individuals have fuller eyebrows and a prominence of
the nasal bridge, with fewer structural abnormalities; however, all
patients had some degree of mental retardation (Deardorff et al.,
2007; Rohatgi et al., 2010). This suggests that brain development
is particularly sensitive to disruption of SMC subunits.
RAD21 (OMIM 606462) mutations also cause a cohesinopa-
thy syndrome (Deardorff et al., 2012b). Heterozygous deletions of
RAD21 and missense mutations, which included a dominant inter-
fering mutation and one with essentially no function, gave rise to
developmental anomalies with some overlap with CdLS. Patients
with RAD21 mutations have an even milder phenotype than those
with SMC mutations. They have some divergence in the facial fea-
tures and, most notably, they have extremely mild cognitive and
physical abnormalities (Deardorff et al., 2012b). Consistent with
RAD21 having a role in DNA damage response, lymphoblastoid
cell lines from patients with RAD21 mutations exhibited radiation
sensitivity. A gene transcription assay in zebrafish showed that
RAD21 missense mutations present in patients are not competent
for proper regulation of gene expression (Deardorff et al., 2012b).
Homozygous recessive mutations in the ESCO2 gene, which
encodes a CoAT, cause another cohesinopathy, RBS (OMIM
268300; Schule et al., 2005; Vega et al., 2005, 2010; Gordillo et al.,
2008). RBS is characterized by mild to severe growth deficiency,
limb malformations (in particular, symmetric tetraphocomelia),
multiple craniofacial abnormalities including cleft lip and/or cleft
palate, microcephaly, and mental retardation. Mortality is high
among severely affected pregnancies and newborns (Gordillo et al.,
1993). A milder disorder with less marked limb reduction and
survival to adulthood is known as SC phocomelia, but since both
disorders arise from ESCO2 mutations with no apparent geno-
type/phenotype correlation (Schule et al., 2005; Vega et al., 2010),
it has been proposed all ESCO2 mutations be referred to as RBS
(Vega et al., 2010). Unlike CdLS, cells from RBS patients exhibit
precocious sister chromatid separation, particularly at heterochro-
matic regions of the chromosomes (Schule et al., 2005; Vega et al.,
2005) leading to mitotic defects, lagging chromosomes, aneu-
ploidy, and micronuclei formation. The acetyltransferase activity
of ESCO2 appears to be crucial, since mutations in this domain
are sufficient for the pathogenesis of RBS (Gordillo et al., 2008).
While RBS features overlap with those of CdLS, there are apprecia-
ble differences. Whether gene regulation downstream of ESCO2 is
responsible for RBS pathology is still under debate.
The wide spectrum of human developmental phenotypes
owing to cohesin mutations characterized to date indicate that
although these disorders have many features in common, there are
also distinct differences. Gene expression and molecular studies
in cells and in animal models have helped to uncover the com-
mon and divergent pathways that lie downstream of cohesinopathy
mutations.
CHARACTERIZATION OF COHESINOPATHY MUTATIONS
REVEALS THAT DISTINCT PATHWAYS ARE AFFECTED BY
DIFFERENT COHESINOPATHY MUTATIONS
A comparison of the consequences of knocking down cohesin or
its regulators in different animal model systems indicates there are
a wide variety of outcomes for cell biology and gene expression.
For mutations causing CdLS and similar cohesinopathies, it seems
likely that specific developmental pathways are regulated down-
stream of the causative gene mutations. Several groups have con-
ducted analyses of gene expression downstream of cohesinopathy
mutations.
For some genes, it seems likely that small changes in the dose
of cohesin or its regulators could have a large impact on tran-
scription. In Drosophila, cohesin and Nipped-B bind to actively
transcribed regions of the genome and are excluded from regions
of polycomb group (PcG) silencing (Misulovin et al., 2008). For
the rare genes where cohesin binding overlaps with PcG-mediated
methylation of lysine 27 on histone 3 (H3K27me3), expression
of those genes is hypersensitive to cohesin dose (Schaaf et al.,
2009). In addition, cohesin ablation in post-mitotic neurons in the
Drosophila mushroom body (Pauli et al., 2008; Schuldiner et al.,
2008), or salivary glands (Pauli et al., 2010) affected the expression
of specific loci including the gene encoding the ecdysone receptor.
This suggests that some genes, perhaps in specific cell types, may
dramatically change their transcriptional activity in response to a
slight alteration of cohesin dose.
Intriguingly, it seems that the transcriptional response of some
genes to cohesin or Nipped-B depletion is biphasic, and depends
on the degree to which these proteins are depleted (Schaaf et al.,
2009). The Enhancer of split gene complex (E(spl)-C) in Drosophila
is exquisitely responsive to Rad21 and Nipped-B levels. Further-
more, when mRNA encoding these proteins is depleted in BG3
cells, the direction in which some E(spl)-C are regulated depends
on the length of time of RNAi treatment, and the degree of
Rad21 or Nipped-B knockdown. For example, E(spl)-C tran-
scripts decrease after 3 days of Nipped-B RNAi, but increase by
day 6 (Schaaf et al., 2009). These findings have implications for
genome-wide gene expression studies in cohesinopathy models.
Which genes are altered in expression is likely to depend on tis-
sue type, developmental stage and degree to which cohesinopathy
gene function has been knocked down.
On the other hand, loss of Nipbl also appears to result in low
(≤2) fold changes in the expression of a great many genes. Liu
et al. (2009) analyzed gene expression and genome-wide binding
of cohesin in lymphoblastoid cell lines from CdLS probands with
mutations in NIPBL or in the cohesin subunit SMC1A, and found
that∼1500 genes (FDR≤ 0.05) were dysregulated compared with
controls. Dysregulated gene expression in the mutant cell lines was
conserved, and correlated with disease severity and cohesin bind-
ing at misexpressed genes (Liu et al., 2009). Significantly, a panel
of 23 genes could differentiate NIPBL mutations from SMC1A
and ESCO2 mutations indicating that NIPBL mutations have a
distinguishable effect on gene expression.
Heterozygous mice carrying a gene-trap insertion into the Nipbl
locus show many features overlapping with CdLS, and microar-
ray analyses indicated that reducing Nipbl dose resulted in small
changes in expression of a great many genes. These mice also had
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severe developmental phenotypes, including craniofacial dysmor-
phology and heart defects, resembling CdLS. Of note was the
altered expression of genes involved in fat metabolism, which
could account for the lean habitus observed in mice and in CdLS
patients (Kawauchi et al., 2009).
Mice with mutations in Pds5a and 5b have also been generated.
Mice homozygous null for Pds5b died shortly after birth, with
multiple congenital anomalies, including heart defects, cleft palate,
skeletal defects, gut defects, abnormal migration and axonal pro-
jections of sympathetic neurons, and germ cell depletion (Zhang
et al., 2007). Mice null for Pds5a exhibit many of the same
multiple abnormalities that were previously observed in Pds5b-
deficient mice, plus additional abnormalities including renal age-
nesis (Zhang et al., 2009). Elimination of both Pds5a and 5b gave
an additional lens phenotype not observed in single null mice,
and resulted in embryonic lethality (Zhang et al., 2009). Gene
expression studies in the Pds5 mice have not been published.
Most recently, significant knowledge about cohesin function
was gained by generating mice deficient for cohesin subunit SA1
(Cuadrado et al., 2012; Remeseiro et al., 2012a,b). Loss of SA1
results in embryonic lethality, and heterozygous animals have
shorter lifespan and increased aneuploidy as a result of chromo-
some segregation defects. Segregation defects arose from com-
promised telomere replication, which requires cohesion mediated
specifically by cohesin-SA1. The resulting aneuploidy in SA1 het-
erozygotes is thought to lead to early onset of tumorigenesis in
these animals (Remeseiro et al., 2012a).
Interestingly, gene expression and genome-wide distribution
of cohesin binding are dramatically altered in SA1 null mice,
with important implications for CdLS. Location of cohesin to
gene promoters and CTCF binding sites appears to depend on
SA1. Furthermore, SA1 ablation led to altered cohesin binding
at particular gene clusters accompanied by dysregulation of their
transcription (Remeseiro et al., 2012b). These studies highlight the
function of SA1 in multiple processes, and identify a key transcrip-
tional role that is distinct from the function of SA2 in centromeric
chromosome cohesion.
Zebrafish models have also shed light on the role of cohesin and
Nipbl in gene expression. In fact, the first published evidence that
cohesin regulates gene expression in a vertebrate model system
came from a forward genetic screen in zebrafish. This screen iden-
tified the Rad21 subunit as a tissue-specific regulator of runx1,
which encodes a hematopoietic transcription factor (Horsfield
et al., 2007). In rad21 mutants at 12 h post-fertilization (hpf),
runx1 expression was retained in Rohon–Beard neurons, but was
absent from a discrete population of cells in the hematopoietic
mesoderm. Importantly, the hematopoietic mesoderm precur-
sor cell population was still present in mutants, and expressed
the dimerization partner for Runx1, cbfb, although not runx1
itself. Cohesin probably targets other runx genes in a cell type-
specific manner, since rad21 mutants also lacked expression of
runx3 in Rohon–Beard neurons and the lateral line primordia
(Horsfield et al., 2007). Unfortunately, the onset of runx2 expres-
sion (∼48 hpf) in zebrafish embryos is too late to determine
its involvement, since rad21 mutants arrest in development at
35 hpf. Like in Drosophila, cohesin is likely to regulate expres-
sion of genes in zebrafish brain; cohesin subunits are expressed in
non-proliferating neurons of zebrafish brain implying a non-cell
cycle role for cohesin in this tissue (Monnich et al., 2009).
A zebrafish model of NIPBL-mediated CdLS revealed much
about the multifactorial origins of this developmental syndrome.
Zebrafish have two copies of the nipbl gene, and depletion of both
versions by morpholino oligonucleotides to create “morphants”
also led to small-scale dysregulation of a large number of genes
in early embryogenesis (up to 6 hpf; Muto et al., 2011). Because
gene expression changes were measured at early gastrula stages it
is likely that many are directly caused by reduced Nipbl function
rather than by secondary effects. Interestingly, genes involved in
endoderm development and left-right axial patterning including
sox17 and foxa2, were specifically downregulated in endoderm.
Dysregulation of the endoderm-specifying hierarchy of Sox32,
Sox17, and Foxa2 by Nipbl depletion is likely to contribute to
the heart looping defects and gut tube defects observed at later
stages in Nipbl-depleted zebrafish embryos (Muto et al., 2011).
The zebrafish pathologies recapitulate heart and gastrointestinal
tract abnormalities observed in CdLS, thereby allowing insight
into the etiology of CdLS developmental defects.
Our own group conducted Affymetrix microarray analyses at
a later stages (24 and 48 hpf) of zebrafish development in rad21
mutants (Rhodes et al., 2010), esco2 morphants (Monnich et al.,
2011), smc1a mutants (available as part of an insertion mutant
collection; Amsterdam et al., 2004) and nipbl morphants (Maren
Mönnich, Cristin G. Print, Julia A. Horsfield, unpublished data).
Interestingly, we found that the eomes gene, a master regulator
of endoderm formation, is consistently downregulated in rad21
and smc1a mutants, and nipbl morphants (FDR< 0.02), support-
ing a role for cohesin and Nipbl in endoderm formation. Eomes
expression is regulated by pluripotency factors Nanog, Oct4, and
Sox2 (Teo et al., 2011), all of which are transcriptional targets of
cohesin and Nipbl in embryonic stem cells (Kagey et al., 2010). It
is enticing to speculate that cohesin and Nipbl could participate
in the initial specification of germ layers from stem cell precursors
through modulating the expression of pluripotency factors.
We expected our microarray analyses of zebrafish cohesinopa-
thy mutants and morphants to result in similar lists of up- or
downregulated genes, since embryos were analyzed at similar
stages and cohesinopathy genes would be predicted to have similar
roles in gene expression. Therefore we were surprised to find only
modest overlap between regulated gene sets (example in Figure 2).
Strikingly, a comparison of rad21 mutant microarray data
with esco2 morphant microarray data revealed that there is scant
overlap between genes regulated downstream of these mutations
(Monnich et al., 2011). For example, the myca gene, which is down-
regulated in rad21 zebrafish mutants and other species as well, is
actually slightly upregulated in esco2 morphants. Most of the genes
regulated downstream of esco2 are involved in cell proliferation or
apoptosis, whereas many genes affected by the rad21 mutation are
developmental regulators (Monnich et al., 2011). What could be
the reason for these differences? We concluded that while Esco2
and Rad21 have related roles in sister chromatid cohesion, they
do not have the same input into the regulation of gene expres-
sion. We found that although esco2 depletion has mild effects on
neural crest cell migration, it does not induce patterning defects.
Instead, even modest esco2 depletion results in robust activation of
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caspases, p53/mdm2 upregulation, and massive cell death (Mon-
nich et al., 2011). Loss of jaw elements and fin stunting in esco2
morphants, which resemble RBS features, are therefore likely to
be due to insufficient cells to contribute to the affected structures.
In agreement with results from a conditional mouse knockout
of Esco2 (Whelan et al., 2012b), it appears that developmental
defects observed in esco2 morphant zebrafish arise from prob-
lems with cell survival rather than dysregulation of developmental
genes.
Our microarray data of nipbl morphants was conducted under
very mild knock down conditions of both nipbl genes at 24 and
48 hpf (Table 2; Maren Mönnich, Cristin G. Print, Julia A. Hors-
field, unpublished data). We observed regulation of different sets
of genes than those found by Muto et al. (2011) at the earlier
timepoint of 6 hpf, which is not unexpected due the different
developmental stage at which embryos were analyzed. We did not
find any Gene Ontology categories of significance other than ele-
vated expression of a network of genes related to p53. It is possible
that degree of nipbl gene knockdown could also contribute to dif-
ferences observed in regulated genes as discussed above, since at
least some gene expression is likely to be sensitive to the dose of
Nipbl protein (Schaaf et al., 2009).
Many genes that have altered regulation in response to deple-
tion of cohesinopathy genes are different, raising the possibility
that cohesin subunits and regulators have different functions in
various pathways. However, genome-wide analyses of gene expres-
sion identified some commonly regulated pathways/genes such as
those involved in endoderm development (eomes, sox17, foxa3),
the myc transcription factor (except in esco2 morphants), and
downstream effectors of Notch signaling such as hey1, her4.2,
and ascl1.
COMMON PATHWAYS REGULATED BY COHESINOPATHY
GENES
Despite varying outcomes for gene expression and development
identified using animal models of the cohesinopathies, some path-
ways seem more likely to be affected than others downstream of
cohesinopathy genes. Common themes of pathways regulated by
cohesinopathy genes are outlined below.
GROWTH, METABOLISM, AND PLURIPOTENCY
Perhaps not surprisingly, several studies have found links between
cohesin and its regulators, and the control of pathways that under-
pin cell growth and proliferation. Somewhat more surprisingly, the
level at which cohesin regulates growth and metabolism includes
transcriptional control of specific gene targets. For example, the
Myc oncogene is positively regulated by Nipbl and all cohesin
subunits investigated to date (Misulovin et al., 2008; Kawauchi
et al., 2009; Liu et al., 2009; Rhodes et al., 2010; Remeseiro et al.,
2012b). Myc is a pluripotency factor, and it is probably signifi-
cant that genes encoding other pluripotency factors Oct4, Nanog,
and Sox2, are also bound and regulated by cohesin (Kagey et al.,
2010; Nitzsche et al., 2011). Interestingly, pluripotency factors, e.g.,
Oct4 (Kim et al., 2011) and Nanog (Nitzsche et al., 2011) in turn
appear to combine with cohesin to both positively and negatively
regulate other target genes. These findings raise the interesting
possibility that cohesin-mediated transcription is pivotal to cell
fate decisions that determine the balance between pluripotency
and differentiation (Dorsett, 2010).
Cohesinopathy genes regulate other growth pathways as well. In
yeast, cohesinopathy mutations, including an Eco1RBS mutation
(W216G), block transcription of ribosomal RNA genes thereby
directly influencing ribosome biogenesis, protein translation and
the cell’s ability to grow (Bose et al., 2012). This finding links
cohesin function to metabolism and growth through a role in
rDNA transcription and translation regulation. Since Myc, a tran-
scriptional target of cohesin, also regulates ribosome biogenesis
(Eilers and Eisenman, 2008), cohesin appears to be a central regu-
lator of growth by transcriptional control of multiple pathways. In
Nipbl+/− mice, genes controlling fat metabolism are dysregulated
(Kawauchi et al., 2009), indicating a direct involvement in regula-
tion of another metabolic pathway. Consistent with dysregulated
growth and metabolism, CdLS patients are small and lean (Liu
and Krantz, 2009). It is possible that many of the large number of
dysregulated genes in CdLS are targets of MYC, which regulates
10–20% of genes in the genome.
Transcriptional regulation of cell growth and proliferation
pathways by cohesin could be elegantly intertwined with its role in
the cell cycle, where it mediates sister chromatid cohesion. Tran-
scriptional pathways promoting growth are tightly linked to cell
division, and it is entirely possible that cohesin and its regulators
have central roles in making these links.
NEURONAL DEVELOPMENT AND THE TRANSCRIPTION OF NEURONAL
GENES
Neurodevelopmental disorders are among the most conserved fea-
tures of the cohesinopathies (Deardorff et al., 2007). It is possible
that these neurodevelopmental pathologies have a common mol-
ecular basis. Several lines of evidence suggest that cohesinopathy
proteins influence the Notch signaling pathway, although the exact
mechanisms are unknown. A recent study suggested that Esco2
physically interacts with Notch to antagonize Notch signaling, sug-
gesting that one possible mechanism includes direct interaction
with Notch receptor(s; Leem et al., 2011).
Our microarray analyses of zebrafish “cohesinopathy” embryos
depleted for Rad21, Smc1a, Nipbl, or Esco2 identified conserved
regulation of selected gene targets of the Notch signaling pathway.
Notably, we found that the ascl1 gene is downregulated in both
rad21 mutants (Horsfield et al., 2007; Rhodes et al., 2010) and
esco2 morphants (Monnich et al., 2011), as well as Nipbl-depleted
embryos and smc1a mutants (Table 2; Maren Mönnich, Cristin
G. Print, Julia A. Horsfield, unpublished data). In 48 hpf rad21
heterozygous embryos (which are phenotypically normal), ascl1 is
significantly downregulated (Rhodes et al., 2010), indicating that
ascl1 expression is highly sensitive to even a slight reduction of
Rad21 (heterozygotes have 60–70% of wild type rad21 mRNA lev-
els). Such sensitivity could have high functional significance. Ascl1
is a potent neuronal lineage-specifying gene, being one of three
genes sufficient to convert fibroblasts into iPN cells (Vierbuchen
et al., 2010). Furthermore, Pds5b depletion altered Ascl1 expres-
sion and blocked neuronal differentiation in a stem cell model
(Denes et al., 2010).
We also found that certain Notch signaling targets of the
hairy/enhancer of split family (such as her4, hey1) were consistently
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95 affected in our zebrafish cohesinopathy models (Rhodes et al.,
2010), in agreement with cohesin/Nipbl regulation of the (E(spl)-
C) in Drosophila (Schaaf et al., 2009). In combination with pre-
vious gene expression studies from Drosophila (Dorsett, 2009),
strong evidence supports a link between cohesin-mediated tran-
scription and cell fate in neuronal linages.
In addition to neuronal cell fate, it appears that cohesin together
with CTCF could contribute to maintaining neuronal identity.
Several studies show that cohesin and CTCF regulate expression
of protocadherin genes (Kawauchi et al., 2009; Monahan et al.,
2012; Remeseiro et al., 2012b). Cohesin-SA1 binds to the promoter
of protocadherin genes and positively regulates their expression
(Remeseiro et al., 2012b). Interestingly, CTCF and cohesin were
recently found to modulate isoform expression of Pcdhα in a
mouse neuroblastoma cell line (Monahan et al., 2012), by a mech-
anism assumed to involve enhancer-promoter communication.
Cohesinopathy mutations could therefore have significant con-
sequences for neuronal recognition of “self,” and the capacity to
make functional synaptic connections (Dekker, 2012), since pro-
tocadherins are key players in these processes (Frank and Kemler,
2002; Esumi et al., 2005).
Evidence suggests that the widespread disruption of neuronal
gene expression found in cohesinopathy mutants results in abnor-
mal behavior and function of neurons. As discussed previously,
localized disruption of cohesin subunits causes failure of axon
pruning in the Drosophila mushroom body (Pauli et al., 2008;
Schuldiner et al., 2008). Other model systems have highlighted a
role for cohesinopathy proteins in axon pathfinding and/or migra-
tion. For example, Mau2, the Scc4 homolog that binds to Nipbl,
is necessary for proper axon guidance and migration in C. elegans
(Seitan et al., 2006). Consistent with a requirement of cohesin for
migration, enteric neurons derived from neural crest cells failed to
migrate in mice mutant for cohesin subunit Pds5b (Zhang et al.,
2007). Furthermore, in esco2 morphant zebrafish, we observed
defects that were consistent with abnormal neural crest cell migra-
tion (Monnich et al., 2011). In zebrafish mutant for rad21, we
observed that while the trigeminal ganglia of the brain are spec-
ified, the axons clump together rather than extending forward
(Figure 3). It is very likely that more subtle defects that are not
FIGURE 3 | Flat-mount staining (anti-HNK-1) of trigeminal ganglia in
wild type (left) and rad21 mutant (right) zebrafish embryos. In rad21
mutants, central neuronal clumping occurred (arrow), and axons failed to
migrate and populate anterior regions (red oval).
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so easily observed (for example, problems with neuronal connec-
tivity) take place in the central nervous system of cohesinopathy
patients and animal models.
Growth, metabolism, and development of the central ner-
vous system appear to be processes that are universally sen-
sitive to cohesinopathy mutations. Much of this pathology is
likely to be caused by cohesin’s role in the regulation of gene
expression. However, cohesin has another important role in
the repair of DNA damage, and its loss is likely to trigger
DNA damage checkpoints (Jessberger, 2009; Watrin and Peters,
2009). Activation of cell cycle checkpoints by cohesin deple-
tion may represent additional biological processes contributing
to cohesinopathies.
COHESINOPATHY GENES, DNA DAMAGE, AND CELL CYCLE
CHECKPOINTS
When damaged DNA is detected, cells respond by coordinating
cell cycle arrest, DNA repair, and programmed cell death (Ciccia
and Elledge, 2010). The crucial roles of cohesin and its regulators
in DNA damage repair have been recently and comprehensively
reviewed elsewhere (Dorsett and Strom, 2012; Wu and Yu, 2012).
Inability to repair DNA and proceed through the cell cycle is
accompanied by activation of cell cycle checkpoints, followed by
cell death in the absence of repair.
Interestingly, mutations in other genes responsible for the
DNA damage response underlie human syndromes with phe-
notypes that overlap the cohesinopathies (Ciccia and Elledge,
2010). Overlapping phenotypes include microcephaly, growth
defects, neurological disorders, and facial/skeletal dysmorphol-
ogy. These features are among the most conserved between the
cohesinopathies, and raise the possibility that defects in the DNA
damage response pathway might contribute to the etiology of
cohesinopathy syndromes. In support of this, a patient with a
mutation in a gene encoding the DNA helicase DDX11/ChlR1
had microcephaly, premature sister chromatid separation, and
genome instability. This patient had features of both Fanconi
Anemia (associated with other DNA helicases involved in DNA
damage repair, XPD, and FANCJ) and RBS, in which ESCO2
is mutated. The syndrome, known as Warsaw Breakage Syn-
drome, is considered to reside at an interface between DNA
damage repair and sister chromatid cohesion (van der Lelij et al.,
2010).
It is possible that the CoAT ESCO2 has a particularly crucial
role in DNA damage repair, since mutations in ESCO2 appear to
resemble mutations in DNA damage repair pathways more than
the other cohesinopathies do. Indeed, ESCO2-depleted cells are
hypersensitive to DNA damaging agents such as Mitomycin C (van
der Lelij et al., 2009; Whelan et al., 2012a). Acetylation of SMC3 is
necessary for S phase checkpoint activation and cell survival (Kim
et al., 2010a), which might explain the absolute requirement for
ESCO2 at this stage of the cell cycle.
Other cohesinopathy mutations also have potential to com-
promise DNA damage repair. Mice heterozygous for a Rad21
null mutation are hypersensitive to IR, and exhibit problems
with integrity and maintenance of the gastrointestinal tract
and hematopoietic system post-irradiation (Xu et al., 2010). In
humans, patients with RAD21 mutations also have impaired DNA
damage repair (Deardorff et al., 2012b), and knock down of
RAD21 sensitizes breast cancer cells to chemical agents that dam-
age DNA (Atienza et al., 2005; Xu et al., 2011). Therefore, full
dosage and function of the Rad21 gene is crucial for DNA damage
repair. In addition, depletion of SMC1 sensitizes HeLa cells to DNA
damage (Bauerschmidt et al., 2010). Interestingly, the cohesin reg-
ulator PDS5B (APRIN) and the cohesin subunits RAD21 and
SMC3 were recently found to associate with the BRCA2 protein.
PDS5B appears to have an essential function in both the DNA
damage response and homologous recombination (Brough et al.,
2012).
It is not clear to what extent DNA damage repair defects con-
tribute the pathology of cohesinopathies (Dorsett and Strom,
2012), but evidence suggests that most cohesinopathy mutations
are likely to impact on the cell cycle in intra-S and G2 phases,
when DNA damage repair takes place. Insufficiency of DNA dam-
age repair should lead to checkpoint activation and cell death,
potentially resulting in a paucity of cells for adequate develop-
ment. However, many cohesinopathy mutations give rise to altered
transcription of developmental regulators rather than cell cycle
phenotypes, raising the question of how distinct outcomes arise
from mutations in proteins with a related function in the cell
cycle.
A MODEL TO EXPLAIN DIVERSE COHESINOPATHY
PHENOTYPES
We propose a model to explain the diverse phenotypes observed
downstream of cohesinopathy genes, in which different pheno-
types emerge according to the “phase” of the cohesin cycle that
is most affected by a particular cohesinopathy mutation in a
given population of cells (Figure 4). In this model, mutations
affecting cohesin loading and its residency times on chromatin
in interphase have a higher potential to influence the regula-
tion of gene expression, since this function can be exquisitely
sensitive to cohesin dose. Alternatively, mutations affecting the
“cohesive” form of cohesin have more potential to impact on
cell division, DNA damage repair, and cell cycle checkpoints.
The consequences are that the latter mutations will affect sister
chromatid cohesion, and initiate cell death pathways. Shared phe-
notypes such as microcephaly, craniofacial defects, and cognitive
impairment are likely to lie at the interface between these two
pathways.
It is important to note that cohesin subunits and the
cohesin loading kollerin complex participate in all cohesin-related
processes, including transcription regulation during interphase,
chromatid cohesion during S phase, and DNA damage repair.
Therefore mutations in genes encoding these proteins have poten-
tial to disrupt all the processes shown in the model (Figure 4).
However, diverse outcomes from different cohesinopathy muta-
tions could result if certain processes have differential sensitivity
to loss of cohesin components and regulators, in distinct cell
populations.
For example, zebrafish embryos zygotic null for rad21 con-
tain heavy maternal loading of Rad21 protein and are able to
develop for about 20 h before cell cycle deficiencies halt growth.
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FIGURE 4 | Model for diverse cohesinopathy phenotypes. In interphase
(red shading), cohesin binding to chromatin is dynamic, with varying residency
times. Interphase cohesin binding is likely to be cell type-specific and to
contribute toward regulating developmental genes. Mutations in cohesin
subunits and their key interphase regulators (e.g., Nipbl, Hdac8) primarily
impact on the regulation of gene expression, including transcriptional
regulation of growth pathways. This results in syndromic developmental
defects that derive from dysregulated transcription, with the possibility of cell
death as a contributing factor. From S phase to G2/M (blue shading), the
overriding function of cohesin involves sister chromatid cohesion and DNA
damage repair. Key regulators in this process include the CoAT ESCO2 and
other DNA damage repair proteins. Mutations in these regulators result in
chromosome segregation defects, genomic instability, and cell death.
Increased cell death and reduced cell proliferation results in too few cells to
make up body structures, leading to a different class of developmental defects
and dysregulation of metabolic pathways. Transcription of a small subset of
hypersensitive genes, including some in the Notch signaling pathway, appears
to be sensitive to both interphase and S/G2 modes of cohesin binding.
However, well before cell cycle defects have any impact, rad21 null
embryos fail to activate runx1 expression in the hematopoietic
mesoderm (Horsfield et al., 2007). Thus, there is a threshold level
of cohesin essential for runx1 expression that is below the level nec-
essary to sustain cell division. The primary impact of suboptimal
levels of Rad21 is that of altered gene expression in a subpopula-
tion of cells, and the secondary impact of cell cycle arrest is not
observed until Rad21 levels are further depleted. Radiation sensi-
tivity observed in Rad21 heterozygous mice (Xu et al., 2010) and
in cells of patients with compromised RAD21 function (Dear-
dorff et al., 2012b) indicates other functions of Rad21 are also
dose-sensitive.
In summary, the phenotypic outcome of cohesinopathy muta-
tions may differ between cell populations and in any given
cell population, depend upon the degree of sensitivity of gene
expression to cohesin levels, the requirement for cell prolif-
eration, and the presence of environmental stressors such as
DNA damaging agents. There is likely to be significant overlap
in these contributing factors to cohesin-related developmental
disorders.
CONCLUSION
Although considerable progress has been made over the last
10 years in the understanding of cohesin function in the cell
cycle, transcription, and human developmental disease, impor-
tant questions remain. How is the transcriptional role of cohesin
coordinated with its role in genome organization, cell division,
and DNA repair? Why do some cohesinopathy mutations lead to
developmental gene dysregulation, while others lead to chromo-
some segregation defects and cell death? Human syndromes and
animal models have potential to lend important insight into the
integration of cohesin functions in cell division and development.
Continued research will be vital for understanding the pathol-
ogy of cohesinopathy syndromes, and the development of future
potential for clinical management or therapy.
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